ProShare Advisors LLC - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 114 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q3 2023$55,156
-11.1%
27,170
+0.7%
0.00%
Q2 2023$62,059
-15.4%
26,982
+11.4%
0.00%
Q1 2023$73,384
+14.3%
24,219
-12.1%
0.00%
Q4 2022$64,210
+36.6%
27,558
+12.4%
0.00%
Q3 2022$47,000
-26.6%
24,515
+3.4%
0.00%
Q2 2022$64,000
-31.2%
23,713
-23.7%
0.00%
Q1 2022$93,000
-34.5%
31,080
-15.1%
0.00%
Q4 2021$142,000
+5.2%
36,599
+16.3%
0.00%
Q3 2021$135,000
+18.4%
31,477
-16.2%
0.00%
Q2 2021$114,000
+192.3%
37,580
+219.8%
0.00%
Q1 2021$39,000
-17.0%
11,750
-10.3%
0.00%
Q4 2020$47,000
+104.3%
13,104
-14.9%
0.00%
Q3 2019$23,000
-45.2%
15,394
-24.3%
0.00%
Q2 2019$42,000
-48.1%
20,342
-10.3%
0.00%
Q1 2019$81,000
-5.8%
22,682
+0.7%
0.00%
-100.0%
Q4 2018$86,000
-66.1%
22,521
-16.3%
0.00%
-50.0%
Q3 2018$254,000
+25.1%
26,911
-3.3%
0.00%
+100.0%
Q2 2018$203,000
+59.8%
27,835
+9.4%
0.00%0.0%
Q1 2018$127,000
-15.3%
25,453
-14.2%
0.00%0.0%
Q4 2017$150,00029,6600.00%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q4 2022
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 3,705,128$10,300,0004.44%
RTW INVESTMENTS, LP 5,666,754$15,754,0000.59%
COWEN AND COMPANY, LLC 926,200$2,575,0000.22%
Hudson Bay Capital Management LP 850,000$2,363,0000.05%
LADENBURG THALMANN FINANCIAL SERVICES INC. 1,774,915$4,934,0000.03%
Point72 Asset Management, L.P. 1,897,284$5,274,0000.03%
683 Capital Management, LLC 77,368$215,0000.02%
Secure Asset Management, LLC 10,000$28,0000.02%
Qube Research & Technologies Ltd 166,138$462,0000.01%
Verition Fund Management LLC 174,455$485,0000.01%
View complete list of ARBUTUS BIOPHARMA CORP shareholders